1.14.15.3	(E)-N'-(4-butyl-2-methylphenyl)-N-hydroxyformimidamide	HET0016, almost completely abolishes hypotonic solutions- or 2,4,6-trinitrophenol-induced enhancement of receptor-activated cationic current I(TRPC6)	26997	
1.14.15.3	(E)-N'-(4-butyl-2-methylphenyl)-N-hydroxyformimidamide	HET0016, diminishes TRPC6-like channel activity in myocytes	26997	
1.14.15.3	1,1-dichloroethene	50% of BMO activity is irreversibly lost after oxidation of approximately 25 nmol/mg protein	135253	
1.14.15.3	1,2-cis-dichloroethene	50% of BMO activity is lost after oxidation of 120 nmol/mg protein	135251	
1.14.15.3	1,2-trans-dichloroethene	50% of BMO activity is lost after oxidation of 20 nmol/mg protein	135252	
1.14.15.3	1,7-octadiyne	inhibits oxidation of methyl tert-butyl ether; putative mechanism-based inactivator, strongly inhibitory at 0.1% (v/v)	56837	
1.14.15.3	1-octyne	acts as a mechanism-based inhibitor of AlkB	174800	
1.14.15.3	1-octyne	irreversible inhibition, oxidation product hexylketene or its equivalent, covalently binds to AlkB	174800	
1.14.15.3	11-dodecynoic acid	completely inhibited lauric acid omega-hydroxylation	32016	
1.14.15.3	17-octadecynoic acid	almost completely abolishes hypotonic solutions- or 2,4,6-trinitrophenol-induced enhancement of receptor-activated cationic current I(TRPC6)	39698